Prosight Management’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.01M Sell
157,500
-144,899
-48% -$2.52M 0.52% 27
2026
Q1
$4.8M Buy
302,399
+165,658
+121% +$2.89M 0.79% 26
2025
Q4
$2.43M Sell
136,741
-171,966
-56% -$3.01M 0.5% 30
2025
Q3
$5.72M Buy
308,707
+235,060
+319% +$4.84M 1.33% 26
2025
Q2
$1.58M Buy
+73,647
New +$1.59M 0.39% 34
2024
Q3
Sell
-200,216
Closed -$5.76M 53
2024
Q2
$5.76M Sell
200,216
-218,045
-52% -$6.68M 1.72% 21
2024
Q1
$12.2M Buy
418,261
+323,261
+340% +$9.04M 3.39% 10
2023
Q4
$3.09M Buy
+95,000
New +$2.75M 1.24% 21
2020
Q4
Sell
-8,399
Closed -$386K 49
2020
Q3
$386K Buy
+8,399
New +$390K 0.18% 44

Other funds holding KIDS

Prosight Management's KIDS Position: Q2 2026 in Review

Prosight Management reduced its OrthoPediatrics (KIDS) stake by 48% in Q2 2026, selling an estimated $2.52M and leaving 157,500 shares worth $3.01M. The position accounts for 0.52% of the portfolio, ranked #27.

Prosight Management first reported a position in KIDS in Q3 2020 and has held it in 9 quarters since. The position peaked at $12.2M in Q1 2024. 120 funds tracked by Wall St. Rank hold KIDS as of Q2 2026.

  • Prosight Management held 157,500 shares of OrthoPediatrics worth $3.01M as of Q2 2026.
  • Prosight Management sold 144,899 OrthoPediatrics shares in Q2 2026, an estimated $2.52M.
  • OrthoPediatrics made up 0.52% of Prosight Management's portfolio in Q2 2026, its #27 holding.
  • Prosight Management first reported a position in OrthoPediatrics in Q3 2020 and has held it in 9 quarters since.
  • Prosight Management's OrthoPediatrics position peaked at $12.2M in Q1 2024.
  • 120 funds tracked by Wall St. Rank held OrthoPediatrics as of Q2 2026.

Based on Prosight Management's 13F filing for Q2 2026, filed 14 Aug 2026.